Our top pick for
Molecular Data Inc is a chemicals business based in the US. Molecular Data shares (MKD) are listed on the NASDAQ and all prices are listed in US Dollars. Molecular Data employs 482 staff and has a market cap (total outstanding shares value) of USD$112 million.
|Latest market close||USD$0.8821|
|52-week range||USD$0.85 - USD$11.9|
|50-day moving average||USD$1.0387|
|200-day moving average||USD$1.5499|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-0.2427|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-09)||N/A|
|1 month (2020-12-18)||0.8821|
|3 months (2020-10-16)||-21.24%|
|6 months (2020-07-17)||-69.26%|
|1 year (2020-01-17)||-79.68%|
|2 years (2019-01-16)||N/A|
|3 years (2018-01-16)||N/A|
|5 years (2016-01-16)||N/A|
|Gross profit TTM||USD$100.8 million|
|Return on assets TTM||-27.8%|
|Return on equity TTM||0%|
|Market capitalisation||USD$112 million|
TTM: trailing 12 months
There are currently 157,949 Molecular Data shares held short by investors – that's known as Molecular Data's "short interest". This figure is 7631.2% up from 2,043 last month.
There are a few different ways that this level of interest in shorting Molecular Data shares can be evaluated.
Molecular Data's "short interest ratio" (SIR) is the quantity of Molecular Data shares currently shorted divided by the average quantity of Molecular Data shares traded daily (recently around 1.6 million). Molecular Data's SIR currently stands at 0.1. In other words for every 100,000 Molecular Data shares traded daily on the market, roughly 100 shares are currently held short.
However Molecular Data's short interest can also be evaluated against the total number of Molecular Data shares, or, against the total number of tradable Molecular Data shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Molecular Data's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Molecular Data shares in existence, roughly 0 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Molecular Data shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Molecular Data.
Find out more about how you can short Molecular Data stock.
We're not expecting Molecular Data to pay a dividend over the next 12 months.
Molecular Data Inc., through its subsidiaries, operates in the chemical e-commerce business in the People's Republic of China. The company operates technology-driven platform that connects participants along the chemical value chain through its integrated solutions. It delivers e-commerce solutions, financial solutions, warehousing and logistics solutions, and software-as-a-service suites that are intended to solve pain points for participants in the traditional chemical industry. The company offers its e-commerce solutions through online platform that consists of molbase.com and molbase.cn websites; Moku Data Weixin account; Chemical Community app; and other ancillary platforms. The company was founded in 2013 and is headquartered in Shanghai, the People's Republic of China.
Everything we know about the CDT Environmental Technology Investment Holdings Limited IPO, plus information on how to buy in.
Everything we know about the Viant Technology Inc IPO, plus information on how to buy in.
Steps to owning and managing EVGN, with 24-hour and historical pricing before you buy.
Steps to owning and managing ETL, with 24-hour and historical pricing before you buy.
Steps to owning and managing EQBK, with 24-hour and historical pricing before you buy.
Steps to owning and managing EIGI, with 24-hour and historical pricing before you buy.
Steps to owning and managing ELTK, with 24-hour and historical pricing before you buy.
Steps to owning and managing DNKN, with 24-hour and historical pricing before you buy.
Steps to owning and managing DKL, with 24-hour and historical pricing before you buy.
Steps to owning and managing DMAC, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.